Stryker remains on track to deliver Mako shoulder and spine applications in 2024, CEO Kevin Lobo said in an Aug. 3 earnings call.
The Latest
Four orthopedic surgeons connected with Becker's to answer, "What is the biggest threat to orthopedics from outside the industry?"
Stryker, Johnson & Johnson and Zimmer Biomet posted their second quarter financial results for 2023, and data on their orthopedic sales.
Globus Medical on Aug. 3 posted second quarter sales of $291.6 million.
Stryker on Aug. 3 posted $5 billion in net sales during the second quarter, an 11.2 percent increase year-over-year.
Neal ElAttrache, MD, operated on James Kaprielian, a pitcher for the Oakland Athletics, Aug. 2 at Cedars-Sinai Kerlan-Jobe Institute in Los Angeles.
A civil trial is set to begin on Aug. 7 against Sheridan (Wyo.) Orthopedic Associates and surgeon Brian Laman, MD, after patient Mary Moore filed a suit in 2019 alleging that Dr. Laman declined several times to operate on her…
The number of unnecessary spine and orthopedic surgeries are on the rise in the U.S., with an estimated 50 percent of lumbar spine surgeries deemed unnecessary.
U.S. News & World Report has named its top 30 neurology and neurosurgery hospitals in the U.S. for 2023 and 2024, including five hospitals in California.
U.S. News & World Report has named its top 50 orthopedic hospitals in the U.S. for 2023 and 2024, including five hospitals in Illinois.